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Chemical fluorophores offer tremendous size and photophysical
advantages over fluorescent proteins but are much more challeng-
ing to target to specific cellular proteins. Here, we used Rosetta-based
computation to design a fluorophore ligase that accepts the red
dye resorufin, starting from Escherichia coli lipoic acid ligase. X-ray
crystallography showed that the design closely matched the ex-
perimental structure. Resorufin ligase catalyzed the site-specific
and covalent attachment of resorufin to various cellular proteins
genetically fused to a 13-aa recognition peptide in multiple mamma-
lian cell lines and in primary cultured neurons. We used resorufin
ligase to perform superresolution imaging of the intermediate
filament protein vimentin by stimulated emission depletion and
electron microscopies. This work illustrates the power of Rosetta
for major redesign of enzyme specificity and introduces a tool for
minimally invasive, highly specific imaging of cellular proteins by
both conventional and superresolution microscopies.
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Fluorescent proteins are used ubiquitously in imaging, but theirdim fluorescence, rapid photobleaching, and large size limit
their utility. At ∼27 kDa (∼240 aa), fluorescent proteins can
disrupt protein folding and trafficking or impair protein function
(1, 2). Chemical fluorophores, in comparison, are typically less
than 1 kDa in size, and are brighter and more photostable. These
properties allow chemical fluorophores to perform better than
fluorescent proteins in advanced imaging modalities such as single-
molecule tracking and superresolution microscopies (3, 4).
Site-specific labeling of proteins with chemical fluorophores
inside living cells is challenging because these fluorophores are
not genetically encodable and therefore must be posttranslationally
targeted inside a complex cellular milieu. Existing methods to
achieve this targeting either require large fusion tags [such as
HaloTag (5), the SNAP tag (6), and the DHFR tag (7)] or
have insufficient specificity [such as biarsenical dye targeting
(8) and amber codon suppression (9)]. To achieve a labeling
specificity comparable to fluorescent proteins, we developed
PRIME (PRobe Incorporation Mediated by Enzymes), which uses
Escherichia coli lipoic acid ligase to attach small molecules to a
13-aa peptide tag (Fig. 1A) (10). To make PRIME more useful
for cellular protein imaging, we sought to engineer the system
for the targeting of bright chemical fluorophores. The chal-
lenge, though, is that lipoic acid ligase (LplA) has a small and
fully enclosed substrate-binding pocket that even with exten-
sive structure-guided mutagenesis has not until this point been
able to accommodate large chemical structures.
Results
Synthesis of Resorufin Derivatives for PRIME. We considered
fluorophores for PRIME based on the steric constraints of
LplA. Far-red emitters such as Cy5 and Atto 647N, although
photophysically desirable, are so bulky that binding inside
LplA would require major reconstruction of protein backbone.
Boron-dipyrromethenes (BODIPYs) are small fluorophores
with tunable emission but their hydrophobicity causes non-
specific binding to cells. In comparison, the small red phenox-
azine fluorophore resorufin does not bind to intracellular
structures. It spectrally overlaps with the commonly used fluores-
cent protein mCherry, but resorufin is twice as bright, comparable
to Cy3 (brightness is defined as extinction coefficient multiplied by
fluorescence quantum yield). In addition to its conventional
fluorescence readout, resorufin can also be used for single-
molecule imaging (11), chromophore-assisted light inactivation
(12), and contrast generation for EM by photoxidation (13).
Compared with miniSOG, a genetically encoded dual fluores-
cence/EM tag, resorufin is red-shifted in emission, approximately
nine times brighter, yet ∼40 times smaller (by mass) (14). Resor-
ufin therefore has suitable photophysical attributes for PRIME.
To develop a resorufin ligase, we first synthesized two variants
with carboxylic acid functionalities and different linker lengths
(Fig. 1B), for binding and activation by LplA as adenylate esters.
To incorporate this tricyclic structure into the enzyme binding
pocket, which only has room for the five-membered ring dithio-
lane of lipoic acid, is a formidable challenge. Even if mutagenesis
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could create such a space, it is not clear whether such drastic
changes in the core of the enzyme would be detrimental to LplA
folding and catalysis.
Structure-Based Mutagenesis and Screening for Resorufin Ligase
Activity. We could not detect any resorufin ligation activity using
the wild-type enzyme under forcing conditions (discussed below).
All previous LplA mutants that recognize an unnatural substrate
contain a mutation at Trp37, which we call a “gatekeeper” (Fig.
2A). A Trp37→Val mutation, for example, allows binding to a
small blue coumarin fluorophore (10). Additionally, the Glu20
side chain also sterically limits the substrate binding pocket and
may electrostatically repel negatively charged substrates (15),
such as resorufin. Therefore, we screened the resorufin probes
1 and 2 against a library of nineteen Trp37 single and Glu20/
Trp37 double mutants, in an attempt to detect resorufin ligation
activity. Ligation of resorufin 2 was detected with three LplA mu-
tants, with the single mutant W37VLplA performing the best (SI
Appendix, Fig. S1A), but the ligation efficiencies (less than 20%
conversion in 4 h with 2 μM enzyme) were far too low to be
useful. Crude modeling shows that the Trp37→Val mutation
may sufficiently lengthen the substrate binding tunnel for resorufin
2 as it does for coumarin, but ring 1 of resorufin 2 clashes with the
Arg70 sidechain, which is structurally important for LplA’s sub-
strate binding loop (SI Appendix, Fig. S1B). This steric clash is
worse for the shorter resorufin 1 because its ring 1 is brought closer
to the Arg70 sidechain, which may explain the complete lack of
activity in our screen (SI Appendix, Fig. S1A).
Rosetta Computational Design of a Resorufin Ligase.Although these
results with gatekeeper mutagenesis were disappointing, we imag-
ined that the fully aliphatic linker of our resorufin 2 substrate might
provide sufficient flexibility for it to bind in previously unimagined
ways. A high-quality crystal structure of wild-type LplA in com-
plex with lipoyl-AMP is available (16) and permitted us to explore
the use of Rosetta (17) to computationally expand our search
space for a resorufin ligase. In previous work, computation was
used to alter the specificity of a deaminase enzyme for ammelide
(a one-ring structure) instead of guanine (two rings) (18), a DNA
endonuclease for altered sequence recognition (19), and an amino
acid adenylation domain for leucine instead of phenylalanine (20).
Our problem of engineering LplA to ligate resorufin instead of
lipoic acid presents a significantly greater challenge owing to the
large size and shape difference between the original and new
substrates.
For our design efforts we chose to work with resorufin 2 (referred
to below as “resorufin”) because it alone exhibited detectable
activity in our rationally designed mutant screens. Our design
strategy was to mutate residues at the lipoyl binding pocket while
avoiding mutations near the phosphocarboxylic anhydride bond
known to be important for catalysis. We sought to use Rosetta to
accommodate resorufin-AMP instead of resorufin plus ATP be-
cause the binding order of the latter two is not known, and it is
likely that binding of either causes a conformational change in the
enzyme (16). We used a fixed-backbone Rosetta design procedure
as follows (17). First, a library of low-energy resorufin-AMP
rotamers was prepared, in which the resorufin moiety was allowed
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Fig. 1. Enzyme-catalyzed site-specific ligation of a resorufin fluorophore to a peptide. (A) (Left) In PRIME labeling, an enzyme catalyzes the covalent ligation
of a small molecule probe onto the lysine residue of a 13-aa recognition peptide (LAP) in two steps. First, the probe is activated as an AMP ester; second, the
activated probe is transferred onto LAP. (Right) Natural and unnatural substrates of LplA. Wild-type LplA ligates lipoic acid. In this work, we computationally
designed a triple mutant E20A/F147A/H149GLplA to ligate the red fluorophore resorufin. (B) Syntheses of three potential resorufin substrates for LplA. Resorufin 3
is a difluorinated isostere of resorufin 2. DCM, dichloromethane; DMF, N,N-dimethylformamide; MeCN, acetonitrile; TBAF, tetra-n-butylammonium fluoride;
THF, tetrahydrofuran; TIPS-Cl, triisopropylsilyl chloride.
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Fig. 2. Computational design of a resorufin fluorophore ligase and design analysis by X-ray crystallography. (A) Cut-away views of wild-type LplA, coumarin
ligase, and resorufin ligase in complex with their AMP ester intermediates. Substrate adenylate esters and key substrate binding pocket residues are rendered
in sticks. Cα of labeled residues are shown as gray balls. (Left) Panel from a crystal structure (PDB ID code 3A7R) (16). In coumarin ligase (Middle), the
“gatekeeper” Trp37 is mutated to Val37 to accommodate the coumarin fluorophore. In the designed resorufin ligase (Right), Trp37 is left intact but
Glu20→Ala, Phe147→Ala, and His149→Gly mutations are introduced to accommodate the resorufin fluorophore. The inner surfaces of the substrate binding
pockets were generated using Hollow software (47) and are shown in light blue. The chemical structures of lipoyl-AMP, coumarin-AMP, and resorufin-AMP
are shown below each panel in their approximate binding conformations. (B) Activity of resorufin ligase and other LplA with constituent mutations for the
ligation of 500 μM resorufin 2 to LAP peptide in 90 min with 2 μM enzyme. (C) The crystal structure of resorufin ligase with a nonhydrolyzable substrate
analog, resorufin sulfamoyladenosine, was obtained by X-ray diffraction at 3.5-Å resolution. The substrate binding pocket of the crystal structure (salmon) is
shown here overlaid with the computational structure (gray, from the top-ranked triple mutant design conformer 7_33) in a cut-away view at two different
angles. Resorufin substrates are shown in thick sticks; ligase residues within 4 Å of the resorufin moiety are shown in thin sticks. The chemical structure of
resorufin sulfamoyladenosine and a close-up view of the binding pocket are shown in SI Appendix, Fig. S4 B–D.
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to move, whereas AMP was held constant in the conformation
observed in the LplA·lipoyl-AMP crystal structure. Second, the
resorufin-AMP rotamer library was superimposed onto the AMP
position in the LplA crystal structure with wild-type sequence to
create the starting model for Rosetta calculations. Third, LplA
residues within 6–8 Å of the resorufin moiety were automatically
selected, yielding roughly 24 designable residues (with the exact
number depending on the conformer of resorufin at each given
point during the simulation), resulting in a theoretical sequence
space of 2024. This set included mutations at the gatekeeper
Trp37 and Glu20. Residues near AMP were fixed in identity
and rotameric state throughout the calculations to preserve the
favorable AMP binding energy. Fourth, 1,600 independent
runs of the Rosetta algorithm were implemented, using Monte
Carlo sampling to implicitly explore ∼106 sequences in each
run. Thus, ∼109 out of the 2024 possible sequences were calcu-
lated. The resulting 1,600 energy-minimized computational designs
converged on nine unique LplA sequences. These were filtered
by overall Rosetta score and other criteria of structure quality, then
ranked according to resorufin-AMP binding energy (SI Appendix,
Fig. S2). Strikingly, 190 out of the top 216 designs had an identical
sequence: the triple mutant E20A/F147A/H149G of LplA.
It was surprising to us that this triple mutant contains no
mutation at the gatekeeper residue Trp37. Instead, Rosetta con-
verged on a design that placed the resorufin binding pocket in a
different and unexpected location (Fig. 2A), bent ∼45° with re-
spect to the predicted binding pocket for coumarin in W37VLplA.
Resorufin-AMP twists at the benzylic carbon to enter the cavity
carved out by removal of bulky side chains at residues 20, 147,
and 149.
In Vitro Activity of Resorufin Ligase. In an HPLC assay, this triple
mutant (E20A/F147A/H149GLplA) catalyzed the ligation of resorufin
to the 13-aa ligase acceptor peptide (LAP) in an ATP-dependent
manner, and the product was confirmed by mass spectrometry
(SI Appendix, Fig. S3 A and B). We scanned the excitation and
emission profiles of the peptide-resorufin adduct and found that
ligation did not shift these wavelengths (SI Appendix, Fig. S3C).
Although 2 μMenzyme gave 100% conversion to product in 90 min
(Fig. 2B), under matched conditions the constituent single muta-
tions and the rationally designed W37V mutant exhibited no de-
tectable activity, whereas the double mutants E20A/F147A and
F147A/H149G exhibited greatly reduced activity (Fig. 2B). Quan-
titative analysis of this triple mutant, which we call “resorufin li-
gase,” gave a kcat of 3.4 min
−1 and a KM of 35 μM for resorufin
(SI Appendix, Fig. S3 D and E). This represents an enormous
catalytic enhancement compared to wild-type LplA, whose ligation
of resorufin is below our detection limit. Overall the catalytic ef-
ficiency of resorufin ligase is 81-fold worse than the wild-type
enzyme for lipoic acid ligation (21) but fivefold better than our
best previous fluorophore ligase [coumarin ligase (10)], which was
designed rationally.
Resorufin Ligase Crystal Structure. To determine whether the ac-
tual structure of resorufin ligase matched that of the computa-
tional design, we cocrystallized resorufin ligase in the presence of
resorufin and ATP to generate resorufin-AMP in situ. In the
absence of a protein substrate, we expected resorufin ligase to
retain resorufin-AMP, as the wild-type ligase does with lipoyl-
AMP (16). It was important to obtain a substrate-adenylate
ester-bound crystal structure because binding induces a large
conformational change in the enzyme’s active site (16), such that
the Rosetta-designed binding pocket would not be formed in the
apo ligase. We found, however, that crystals formed this way did
not harbor electron density for resorufin-AMP in the expected
binding site, and the 2.2 Å-resolution structure possessed tertiary
features matching the apo form of wild-type LplA (22) (SI Appendix,
Fig. S4A). Because separate experiments showed that these crystals
were capable of forming resorufin-AMP, we postulated that this
high-energy intermediate dissociated from the active site and
hydrolyzed over the 3-d crystallization period.
We therefore synthesized a nonhydrolyzable substrate analog,
resorufin sulfamoyladenosine (structure in SI Appendix, Fig.
S4B), for cocrystallization. Sulfamoyladenosine analogs have
been used to generate competitive inhibitors of aminoacyl-tRNA
synthetases (23), and biotin sulfamoyladenosine is a competitive
inhibitor of E. coli biotin ligase (24), an enzyme structurally and
functionally homologous to LplA (25, 26). We confirmed that
resorufin ligase was able to bind resorufin sulfamoyladenosine
and proceeded to crystallize the ligase in the presence of this an-
alog. The resulting crystals exhibited a different space group and
produced a 3.5-Å resolution structure after correction for dif-
fraction anisotropy (data processing in SI Appendix, Supporting
Methods and Table S1). We observed clear electron density for
the resorufin substrate (SI Appendix, Fig. S4C) and found that
the crystal structure closely matched the computational design
(Fig. 2C). Resorufin points toward residues 20 and 147, although
an ∼1-Å translation of the resorufin core relative to the design
potentially allows it to form two hydrogen bonds, with Arg140
and His79 sidechains, instead of the one hydrogen bond pre-
dicted by Rosetta (SI Appendix, Fig. S4C). Arg70 does not clash
with the ring 1 of resorufin but instead forms a favorable stacking
interaction (Fig. 2C). Comparing the apo and substrate-bound
structures, we further observed that resorufin ligase undergoes
the same global conformational change as wild-type LplA does
upon substrate binding, including the clamping down of two
substrate binding loops and a ∼180° rotation of the C-terminal
domain (SI Appendix, Fig. S4A). It was interesting to us that the
major cavity carving by Rosetta did not impede these essential
dynamic features of the enzyme.
Protein Labeling in Living Cells with Resorufin Ligase.We proceeded
to test resorufin labeling inside cells. First it was necessary to mask
the acidic groups on resorufin as an acetoxymethyl (AM) ester and
ether to give resorufin-AM2. This probe readily crossed cell
membranes; endogenous esterases then cleave the masking groups
to regenerate resorufin (27). We observed that resorufin-AM2
has two regioisomers, cis and trans (SI Appendix, Fig. S5A).
When we separately tested the retention of the two isomers in
untransfected cells, we found that the trans isomer exhibited less
nonspecific binding, leading to lower fluorescence background
after washout (SI Appendix, Fig. S5B), even though both isomers
entered cells equally well, and their unmasked products are iden-
tical. It is possible that the cis isomer associates more strongly with
intracellular membranes or is a poorer substrate for endogenous
esterases. We therefore performed all subsequent experiments with
pure trans resorufin-AM2. For cellular experiments we relied on
intracellular ATP to effect ligation and endogenous organic anion
transporters to remove excess unconjugated dye during the
washout step following protein labeling (10).
To characterize labeling specificity we transfected human
embryonic kidney 293T (HEK) cells with GFP-tagged resorufin
ligase and LAP-tagged blue fluorescent protein (BFP), then treated
these cells with resorufin-AM2 for 10 min. After a further 45-min
dye washout step we imaged these cells live and observed labeling
only in cells expressing both ligase and LAP, and not in neighboring
cells lacking either or both constructs (Fig. 3A). Resorufin retention
was also not observed in negative controls where LAP-BFP was
replaced by a point mutant (LAP Lys→Ala), or where resorufin
ligase was replaced by wild-type LplA.
We analyzed the lysates of resorufin-labeled cells by SDS/
PAGE and observed a single red fluorescent band at the mo-
lecular weight of LAP-BFP (Fig. 3B). Using a gel-shift assay on
cell lysates, we determined that the labeling yield reached 74% in
HEK cells treated with 5 μM resorufin-AM2 for 30 min (SI
Appendix, Fig. S6).
4 of 9 | www.pnas.org/cgi/doi/10.1073/pnas.1404736111 Liu et al.
Resorufin LAP-BFP GFP-ligase + DIC A B 
40 kDa- 
25 kDa- 
Resorufin 
fluorescence 
Coomassie 
60 kDa- 
1 2 3 1 2 3 
Wild-type ligase 
LAP(K A) 
LAP-MAP2 LAP- -actin LAP-NLS LAP-CaaX 
Vimentin-LAP Vimentin-LAP LAP- -actin LAP- -actin 
HEK Rat neurons 
HeLa COS-7 
H2B-YFP & DIC 
Resorufin 
mApple 
HaloTag-TMR 
C D 
Fig. 3. Site-specific protein labeling with resorufin ligase in living mammalian cells. (A) Human embryonic kidney 293T (HEK) cells coexpressing GFP-tagged resorufin
ligase and LAP-BFP were labeled with 5 μM resorufin-AM2 for 10 min, then washed for 45 min before live-cell imaging. Negative controls are shown with an alanine
mutation in LAP and resorufin ligase replaced by wild-type LplA. (B) Gel analysis of labeling specificity. Cells labeled live as in Awere lysed, resolved by SDS/PAGE, and
visualized by fluorescence (Left) and Coomassie stain (Right). Negative controls using wild-type LplA (lane 2) or a Lys→Ala mutation in LAP (lane 3) showed diminished
signal. (C) Resorufin labeling of various LAP fusion constructs in multiple mammalian cell lines (HEK, HeLa, and COS-7) and rat cortical neurons. Resorufin fluorescence
is overlaid with differential interference contrast image in the lower panels. Labeling specificity of LAP–β-actin and vimentin-LAP compared with immunofluorescence
is shown in SI Appendix, Fig. S7. CaaX, prenylation motif; NLS, nuclear localization signal. (D) Comparison of β-actin labeling in living HeLa cells by resorufin ligase
versus mApple and HaloTag (using tetramethylrhodamine HaloTag ligand). In the latter two cases, actin is frequently excluded from the nucleus. H2B-YFP is
a cotransfected nuclear marker. (All scale bars, 10 μm.)
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Resorufin ligase could specifically label proteins localized to
the nucleus and to the inner leaflet of the plasma membrane as
well as β-actin, the intermediate filament protein vimentin, and
microtubule-associated protein MAP2 with high sensitivity and
specificity inside HeLa, COS-7, and cultured rat neurons (Fig. 3C
and SI Appendix, Fig. S7). Labeling of β-actin in particular illus-
trates the benefits of a small, 2-kDa tag, because analogous
mApple-β-actin (27-kDa tag size) and HaloTag-β-actin (35-kDa
tag size) constructs displayed aberrant localization (Fig. 3D).
Previous studies have also shown that fluorescent protein-tagged
β-actin has impaired dynamics and altered affinity for actin binding
proteins (28).
For extracellular labeling of surface proteins we found it ad-
vantageous to use the fluorinated resorufin 3 probe (Fig. 1B),
whose reduced phenolic pKa compared with resorufin 2 confers
two advantages. First, resorufin 3 is predominantly anionic and
fluorescent at physiological pH (SI Appendix, Fig. S8B), so it does
not leak into cells like resorufin 2 does when supplied at high
concentrations, allowing users to bypass the lengthy washout step to
remove the intracellular fluorophore pool (SI Appendix, Fig. S8C).
Second, resorufin 3 remains bright at reduced pH values,
allowing continued visualization of surface proteins after endo-
cytosis into acidic compartments (SI Appendix, Fig. S8C).
Even though the resorufin excitation and emission wavelengths
do not change significantly upon ligation to LAP (SI Appendix,
Fig. S3C), we observed a fourfold reduction in fluorescence
intensity, which may be due to photoinduced electron transfer
to the +2 Trp of LAP (29). Mutation of this residue to Phe, to
give LAP-F, reduced the intensity drop to ∼1.5-fold (SI Appendix,
Fig. S9B), but the ligation efficiency declined by 1.8-fold in a single-
time-point assay. We therefore recommend the standard LAP for
most applications and LAP-F for experiments such as single-
molecule imaging where fluorophore brightness is crucial.
Using the standard LAP sequence and a 30-min labeling pro-
tocol we observed a greater than 2:1 signal-to-noise ratio in
imaging with as little as ∼0.8 μM of intracellular LAP target
(SI Appendix, Fig. S10). This is similar to the ∼0.5 μM sensitivity
limit of mCherry tagging measured in the same way (SI Appendix ,
Supporting Methods) (30). The reduction of resorufin fluorescence
intensity upon ligation, therefore, does not significantly hinder
labeling sensitivity compared with fluorescent protein tagging.
Orthogonal Fluorophore Recognition by Resorufin and Coumarin Ligases.
Because resorufin and coumarin ligases bind their fluorescent
substrates in distinct binding pockets, we tested whether recogni-
tion by these ligases could be orthogonal. We found that purified
coumarin ligase does not ligate resorufin to LAP and purified
resorufin ligase does not ligate coumarin, even though coumarin
is smaller than resorufin (SI Appendix, Fig. S11 A and B). This
orthogonality enabled us to simultaneously perform resorufin
and coumarin labeling of resorufin ligase-expressing live cells
mixed with coumarin ligase-expressing live cells (SI Appendix,
Fig. S11C). Resorufin was observed to selectively partition to the
former and coumarin selectively to the latter.
For fully orthogonal two-color labeling of different proteins
within the same cell, rather than separate neighboring cells as
shown here, it will be necessary to also engineer orthogonal
LAP sequences.
Imaging via Stimulated Emission Depletion Microscopy and Electron
Microscopy with Resorufin Ligase.Owing to the ∼250-nm diffraction
barrier of visible light, small or densely packed cellular struc-
tures and complexes can only be resolved using superresolution
microscopic approaches. We tested whether resorufin ligase could
be used in conjunction with superresolution fluorescence imaging
by stimulated emission depletion (STED) (31). Living CV-1 cells
expressing LAP-tagged vimentin were labeled with resorufin ligase
and resorufin-AM2. Imaging by STED gave superior differentia-
tion between individual vimentin filament bundles (∼80-nm reso-
lution) compared with conventional confocal microscopy (Fig. 4A).
Electron microscopy (EM) is another powerful approach to
study cellular samples at very high spatial resolution. We ex-
plored the ability of resorufin ligase to generate contrast for EM.
Certain fluorophores in the excited state are known to photo-
oxidize diaminobenzidine (DAB) into a locally deposited poly-
mer (scheme in Fig. 4B) (13, 14, 32). This polymer in turn
recruits osmium, which is electron-dense and gives EM contrast.
We labeled vimentin in COS-7 cells using the LAP-F peptide,
which increased photooxidation efficiency compared with LAP (SI
Appendix, Fig. S9C). After osmium staining we observed dense
deposits by brightfield imaging (Fig. 4B). EM imaging then
revealed the localization of single ∼10-nm-wide vimentin fila-
ments (Fig. 4C). Previous EM of intermediate filaments relied
on extensive detergent extraction to remove confounding fea-
tures such as microfilaments and microtubules (33) or used
immunogold staining, which also must be preceded by detergent
solubilization of membranes to allow antibody access (34). In
contrast, the detergent-free protocol used here preserves cellular
ultrastructure, membranes, and organelles and allowed us to
visualize the relationship between vimentin intermediate fila-
ments and endogenous cellular features. For example, Fig. 4C
shows filaments bordering the cell nucleus and two individual
filaments making apparent contact with a nuclear pore complex.
A role for intermediate filaments in coordinating mechanical
signals with nuclear activities such as transcription has previously
been suggested (35, 36). In another example, we observed a close
juxtaposition of mitochondria to filaments, especially for mito-
chondria in the periphery of the nucleus (Fig. 4C). Direct binding
between vimentin and mitochondria has been suggested (37) and
may play a role in mitochondrial trapping in cellular regions with
high energy demand. Our resorufin ligase methodology provides
a tool to examine the spatial and structural nature of these
relationships.
Discussion
In summary, we have used the enzyme redesign capabilities of
Rosetta computation to create a new technology for protein la-
beling and imaging in living cells. PRIME with resorufin ligase
can be used to study specific cellular proteins in an optimal spectral
window while minimizing steric perturbation to that protein. Thus,
PRIME can be an attractive alternative to red fluorescent proteins
such as mCherry, which is 15 times larger, in cases where bulky tags
are not tolerated [such as for β-actin shown in this work and
neuroligin-1 shown elsewhere (38, 39)]. Our study shows that
despite the posttranslational nature of our labeling the tagging
specificity is exceptionally specific, comparable to that obtained by
direct genetic fusion to fluorescent proteins.
Apart from conventional fluorescence microscopy, we showed
that resorufin PRIME can also be used for superresolution
fluorescence imaging by STED and for EM via photooxidation of
DAB. Such multimodality tags are rare but provide great ver-
satility for biological applications. However, the cost of tag ver-
satility is that resorufin’s photophysical properties are not highly
optimal for either long-term fluorescence imaging or for highly
efficient photooxidation. For example, miniSOG has a 12- to 20-
fold higher quantum yield for 1O2 generation (14, 40), and Cy3
is 30 times more photostable than resorufin (41).
From the standpoint of computational design, our work is no-
table in several respects. First, the redesign from lipoic acid rec-
ognition to resorufin recognition required a larger change in size,
shape, and location of the binding pocket than in previous enzyme
substrate specificity redesigns and began with a wild-type template
that had no detectable activity for resorufin ligation. Despite
this, our design lost less than 102-fold catalytic efficiency com-
pared wild-type activity, whereas a previous redesign of guanine
deaminase lost ∼107-fold catalytic efficiency (18). This enabled
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our designed ligase to have practical utility without the need for
further directed evolution of catalytic efficiency. Second, al-
though ∼109 LplA variants were explored in silico, there was
an unusually strong convergence toward a single sequence, and
the top-ranked conformer of this sequence closely resembled the
actual crystal structure. Our work illustrates the power of com-
putational design to develop enzymes with practical utility for
cell biology.
Materials and Methods
Protein Purification for in Vitro Enzymatic Reactions and Cell-Surface Resorufin
Labeling. LplA mutants with an N-terminal His6 tag and E2p lipoyl domain
were purified as previously reported (42). LplA was dialyzed against and
stored in 20 mM Tris·HCl, pH 7.5, containing 10% (vol/vol) glycerol and 1 mM
DTT, at –80 °C. E2p protein was dialyzed against 20 mM PBS, pH 7.4, and
stored at –80 °C. Protein concentrations were determined by the bicinchoninic
acid assay (Thermo Scientific).
HPLC Assay of Enzyme Activity. Resorufin ligation reactions are typically as-
sembled with 0.5–2 μM enzyme, 200 μM LAP (GFEIDKVWYDLDA), 10–500 μM
resorufin, 2 mM ATP, and 5 mM Mg(OAc)2 in Dulbecco’s PBS, pH 7.4, con-
taining 10% (vol/vol) glycerol. Reactions were carried out at 30 °C and
quenched by addition of ethylenediaminetetracetic acid at 50 mM final
concentration. Reaction mixtures were analyzed by one of two HPLC systems.
In system 1, 50 μL of the quenched mixture was resolved by reverse-phase
HPLC (Varian Prostar) using a C18 column (Microsorb-MV 300–5) under a 25–
60% (vol/vol) acetonitrile linear gradient over 20 min. Both H2O and aceto-
nitrile solvents were supplemented with 0.1% trifluoroacetic acid acid. In
system 2,10 μL of the quenched mixture was resolved by reverse-phase HPLC
(Shimadzu UFLC XR) using a C18 column (Supelco Ascentis Express ES-C18)
under a 25–45% (vol/vol) acetonitrile linear gradient over 10 min. Both H2O
and acetonitrile solvents were supplemented with 0.1% formic acid. Peptide
and resorufin-peptide adducts were quantified by integrating their UV ab-
sorption peaks at 210 nm, with correction from resorufin absorption using
a previously reported method (42). LAP and LAP-F peptides were synthesized
and purified to >95% purity by GenScript.
Cloning and Mutagenesis. LplA mutants for bacterial expression and purifi-
cation were generated by QuikChange mutagenesis using a standard pro-
tocol (Stratagene). E20A/F147A/H149GLplA (resorufin ligase) was generated by
two sequential QuikChange steps (E→A, followed by F→A and H→G) from
the wild-type sequence and was inserted into mammalian expression plas-
mids using standard restriction digestion and ligation protocols.
Mammalian Cell-Line Culture and Transfection. Unless otherwise stated, human
embryonic kidney 293T (HEK), HeLa, and COS-7 cells (all from American Type
Culture Collection) were cultured as a monolayer on 150-μm-thick glass coverslips
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Fig. 4. Superresolution cellular protein imaging with resorufin ligase. (A) Live-cell imaging of resorufin-labeled vimentin intermediate filaments in CV-1 cells
by confocal microscopy (Upper) and STEDmicrocroscopy (Lower). Cross-sectional analysis of vimentin fluorescence is shown at the right. STED (resolution ∼80 nm)
was able to resolve filaments ∼350 nm apart, whereas confocal (resolution ∼300 nm) could not. (B) (Upper) Scheme for resorufin-catalyzed photooxidation of
diaminobenzidine for EM. Resorufin in the excited singlet state (1Resorufin*) undergoes intersystem crossing into the triplet state, which then generates singlet
oxygen (1O2). Singlet oxygen polymerizes diaminobenzidine; subsequent staining by OsO4 generates an electron-dense polymer for EM. (Lower) Osmium-stained
polymers on vimentin intermediate filaments visualized at low magnification under brightfield imaging correlates with resorufin fluorescence. (C) (Left) Vimentin
filaments (solid arrowheads) were observed to contact nuclear pores (hollow arrowhead). (Right) Juxtanuclear mitochondria were observed to be encased by and
associated with vimentin filament bundles. Mito, mitochondrion; NP, nuclear pore; Nuc, nucleus.
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in complete growth medium: MEM (Mediatech) supplemented with 10%
(vol/vol) FBS (PAA Laboratories) at 37 °C and under 5% (vol/vol) CO2. For HEK
cells, coverslips were pretreated with 50 μg/mL human fibronectin (Millipore).
Cells were typically transfected with 200–400 ng plasmid DNA per 1 cm2 at ∼70%
confluence using Lipofectamine 2000 (Life Technologies) according to the
manufacturer’s instructions then labeled 16–24 h after transfection.
Dissociated Rat Neuron Culture and Transfection. All animals were housed and
cared for, and experiments were conducted, in accordance with the Mas-
sachusetts Institute of Technology Committee on Animal Care guidelines
(assurance no. A-3125-01) as specifically approved as part of animal protocol
no. 0910-076-13. Spague–Dawley rat pups were euthanized at embryonic
day 18. Cortical tissue was digested with papain (Worthington) and DNaseI
(Roche), then plated in MEM + L-glutamine (Sigma) supplemented with 10%
(vol/vol) FBS (PAA Laboratories) and B27 (Life Technologies) on glass cover-
slips pretreated wih poly-D-lysine (Sigma) and mouse laminin (Life Technol-
ogies). At 3 d in vitro, half of the growth medium was replaced with
Neurobasal (Life Technologies) supplemented with B27 and GlutaMAX (Life
Technologies). Neuron transfection was performed at 5 d in vitro, using half
the amount of Lipofectamine 2000 recommended by the manufacturer. Cells
were labeled and imaged at 9 d in vitro.
General Protocol for Resorufin Labeling Inside Cells. HEK, HeLa, and COS-7
cells on glass coverslips were rinsed twice with serum-free MEM then treated
with MEM containing 5 μM resorufin 2-AM2 for 10–30 min at 37 °C. The cells
were then rinsed three times with complete growth medium and left at
37 °C for 40 min to 1 h for excess dye to wash out of cells then imaged live in
Dulbecco’s PBS (DPBS), pH 7.4. During dye washout the medium was
replaced with fresh complete growth medium at 10 and 20 min after initial
rinsing to improve washout efficiency.
Dissociated rat neurons on glass coverslips were labeled in the same way
except that they were treated with 2.5 μM resorufin 2-AM2 for 30 min and
dye washout required 2 h in Neurobasal supplemented with GlutaMAX and
B27. Cells were imaged live in Tyrode’s buffer (145 mM NaCl, 1.25 mM CaCl2,
3 mM KCl, 1.25 mM MgCl2, 0.5 mM NaH2PO4, and 10 mM glucose in 10 mM
Hepes, pH 7.4).
Live-Cell Fluorescence Microscopy. HEK, HeLa, and COS-7 cells placed in DPBS
or rat neurons in Tyrode’s buffer were imaged using a Zeiss AxioObserver.Z1
inverted confocal microscope with a 40× or 63× oil-immersion objective. The
spinning disk confocal head was manufactured by Yokogawa. The following
laser excitation sources and filter sets were used: BFP and coumarin (405
excitation, 438/30 emission, 450 dichroic); YFP and GFP (491 excitation, 535/30
emission, 502 dichroic); resorufin, mApple, and TMR (561 excitation, 605/20
emission, 585 dichroic); and Alexa Fluor 647 (647 excitation, 680/30 emission,
660 dichroic). Resorufin imaging at 561 nm was typically performed at
∼50 mW/cm2 irradiance. Acquisition times ranged from 100 to 1,000 ms.
Images were acquired and processed using SlideBook software version 5.0
(Intelligent Imaging Innovations).
Purification of Resorufin Ligase for Crystallization Experiments (Fig. 2C and SI
Appendix, Fig. S4 and Table S1). Resorufin ligase with an N-terminal His6 tag
followed by a Tobacco Etch Virus (TEV) protease cleavage sequence was
expressed in E. coli and purified by immobilized metal affinity chromatog-
raphy as described in Materials and Methods. Purified protein was dialyzed
against LplA buffer [20 mM Tris·HCl (pH 7.5), 10% (vol/vol) glycerol, and 1 mM
DTT] then dialyzed against TEV protease cleavage buffer [50 mM Tris·HCl
(pH 8.0), 0.5 mM EDTA, and 1 mM DTT] and subsequently treated with AcTEV
protease (Life Technologies) at 4 °C for 48 h in the same buffer to remove the
His6 tag. The cleaved tag and AcTEV protease (also contains His6 tag) were
removed by immobilized metal affinity chromatography. The flow-through
containing tag-less resorufin ligase was dialyzed against LplA buffer and fur-
ther purified by size-exclusion chromatography on a Superdex 75 HiLoad
26/600 column (GE Healthcare) developed in LplA buffer at 4 °C, using the
ÄKTA purifier system (GE Healthcare). Elution was monitored at 250 nm ab-
sorbance and the pure fractions were pooled, then concentrated to ∼8 mg/mL
using Amicon ultracentrifugal filter units, 10-kDa molecular weight cutoff
(Sigma-Aldrich).
Determination of the Crystal Structure of Resorufn Sulfamoyladenosine-Bound
Resorufin Ligase (Fig. 2C and SI Appendix, Fig. S4 and Table S1). Crystallization
of the sulfamoyladenosine analog bound structure was carried out in a
hanging drop vapor diffusion setup, using 2 μL of 5.6 mg/mL resorufin ligase
containing 1 mM resorufin sulfamoyladenosine, 1 mM Mg(OAc)2, and 1 mM
DTT mixed with 2 μL of precipitant solution [11% (wt/vol) PEG 20,000 and
0.15 M MES:NaOH, pH 6.5]. Drops were incubated at 4 °C in the dark, and red-
colored crystalline plates appeared after ∼5 d. Crystals were looped and
washed through a cryoprotection solution of 80% (vol/vol) precipitant
solution [12% (wt/vol) PEG 20,000 and 0.2 M MES:NaOH, pH 6.5] and 20%
(vol/vol) glycerol. Crystals were then cryocooled by direct submersion into
liquid nitrogen.
Diffraction data were collected at the Advanced Photon Source and
processed using HKL-2000 (43). Owing to significant anisotropy in the a* axis
of the dataset [determined by the Diffraction Anisotropy Server (44)], blind
regions were included at the top and bottom of each frame during in-
tegration to avoid merging absent reflections into the dataset. Although
resulting data have lower redundancy and lower completeness in the high-
resolution shell compared with the apo data (SI Appendix, Table S1), data
quality was sufficient to solve the structure and evaluate ligand binding.
The ligand-bound structurewas solved bymolecular replacement in Phaser
(45) using a model of lipoyl-AMP–bound LplA with waters and ligands re-
moved [PDB ID code 3A7R (16), Z-score 28.1, 4.5 Å high resolution cutoff].
Four molecules of the ligase were found in the asymmetric unit. Model
building, refinement, and structural validation were carried out as described
in SI Appendix for the “apo” structure, with the exception that non-
crystallographic symmetry (NCS) restraints were used in refinement owing to
the lower resolution. In particular, each of the four monomers in the
asymmetric unit was used as a group for torsion NCS weighting. Statistics for
the final structure are shown in SI Appendix, Table S1.
Live-Cell Resorufin Labeling and Imaging of Proteins in Various Cell Lines (Fig. 3
A, C, and D). Cells were transfected with indicated constructs and labeled and
imaged live as described inMaterials and Methods. Labeling and dye washout
times for HEK cells were 10 min and 45 min, respectively. Labeling and dye
washout times for HeLa and COS-7 cells were 20 min and 1 h, respectively.
Analysis of Resorufin Labeling Specificity by SDS/PAGE (Fig. 3B). HEK cells
grown in a six-well plate (9.5 cm2 per well) were transfected and labeled with
resorufin 2-AM2 as in Fig. 3A (plasmid quantity scaled up proportionally)
then lifted by gentle trituration and lysed by three freeze–thaw cycles in
hypotonic lysis buffer (5 mM MgCl2 and 1 mM Hepes, pH 7.5) containing 1×
protease inhibitor mixture (Sigma) and 500 μM phenylmethanesulfonylfluoride.
The lysate was clarified by centrifugation at 8,000 × g for 10 min at 4 °C.
The supernatant was then boiled in the presence of SDS and resolved on an
8% (wt/vol) SDS polyacrylamide gel. Resorufin fluorescence was imaged
on a Fujifilm FLA-9000 image scanner with 532-nm excitation and a green
long-pass filter. The same gel was then stained by Coomassie and reimaged
under white light.
Comparison of β-Actin Localization with LAP, mApple, or HaloTag (Fig. 3D).
HeLa cells were transfected with H2B-YFP (a nucleus marker) and one of
the following: (i) resorufin ligase + LAP–β-actin, (ii) mApple–β-actin, or (iii)
HaloTag–β-actin. Eighteen hours after transfection, the LAP–β-actin cells were
labeled as in Fig. 3C then imaged live; mApple–β-actin cells were imaged
without further treatment. HaloTag–β-actin cells were labeled with 5 μM
tetramethylrhodamine ligand (Promega) for 15 min then imaged live after
a 30-min washout of excess ligand.
Resorufin Labeling of Vimentin Intermediate Filaments for Live-Cell STED Imaging
(Fig. 4A). CV-1 cells, grown on 18-mm coverslips in 24-well plates, were
cotransfected with GFP-tagged resorufin ligase and C-myc–tagged vimentin-
LAP. The next day, cells were incubated with 10 μM resorufin 2-AM2 for 10 min,
followed by a single rinse and further 60-min incubation in complete growth
medium. Before imaging, cells were washed twice with Opti-MEM medium
(Invitrogen) supplemented with 2 mg/mL glucose. Coverslips were trans-
ferred to custom-made holders, overlaid with ∼500 mL of Opti-MEM, and
imaged at room temperature. The STED setup used has been described
previously (46). Excitation and STED beams were derived from a single super-
continuum laser source with 570-nm and 720-nm light used for excitation and
stimulated depletion of resorufin, respectively. The fluorescence signal was
separated by appropriate filters and detected in the spectral range of 580–620
nm. Representative confocal images were obtained by imaging the sample in
the absence of the STED beam.
Resorufin Labeling of Vimentin Followed by Photooxidation of Diaminobenzidine
for EM (Fig. 4 B and C). COS-7 cells expressing vimentin-LAP and resorufin ligase
grown on poly-D-lysine–coated glass-bottom culture dishes (MatTek) were la-
beled with resorufin 2-AM2 as in Fig. 3C. After dye and colcemid washout, cells
were fixed in 2% (wt/vol) glutaraldehyde (Electron Microscopy Sciences) in
cacodylate buffer (100 mM, pH 7.4) at 4 °C for ∼24 h then rinsed in the same
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buffer three times on ice. Cells were subsequently treated with 50 mM glycine
to quench unreacted aldehydes, followed by 10 mM potassium cyanide and
5 mM aminotriazole in the cacodylate buffer for 20 min on ice to suppress
background. Photooxidation was performed using a Leica SPI II inverted
confocal microscope equipped with a 150-W xenon light source. Labeled
cells were located by epifluorescence and treated with a fresh solution of
diaminobenzidine (prepared by dissolving 5.4 mg diaminobenzidine in 1 mL
0.1 N HCl and diluting to 10 mL total volume using cacodylate buffer;
Sigma). A stream of oxygen gas was blown over the surface of the so-
lution and the cells were illuminated using a 562/40 filter (Semrock) at full
intensity for 10–20 min until a brown reaction product appeared. These illu-
mination conditions are much more intense than for live-cell imaging, such
that most fluorescence was photobleached after the 10- to 20-min treatment.
The cells were then rinsed in cold cacodylate buffer and postfixed with 1%
osmium tetroxide on ice. After rinses in cold water, cells were either stained
with 2% (wt/vol) aqueous uranyl acetate at 4 °C overnight en bloc or directly
dehydrated in cold ethanol series [20, 50, 70, 90, and 100% (vol/vol)] for 3 min
each on ice, followed by a room temperature rinse in 100% ethanol. Cells were
embedded in Durcupan ACM resin (Electron Microscopy Sciences). Standard
80-nm-thick sections were imaged using a JEOL 1200 EX transmission electron
microscope operated at 80 kV. Cells in Fig. 4B were treated with 1 μg/mL
colcemid (Sigma) for 4 h before addition of resorufin-AM2.
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